Katherine A Fitzgerald Selected Research

Katherine A Fitzgerald Research Topics

Disease

57	Infections 01/2020 - 01/2004
39	Bites and Stings (Sting) 01/2022 - 11/2010
38	Inflammation (Inflammations) 10/2022 - 08/2008
17	Virus Diseases (Viral Diseases) 01/2018 - 05/2003
12	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 07/2006
11	Melanoma (Melanoma, Malignant) 01/2021 - 10/2005
10	Malaria 01/2022 - 08/2011
7	Neoplasms (Cancer) 01/2021 - 11/2012
4	Tuberculosis (Tuberculoses) 01/2022 - 07/2009
4	Fibrosis (Cirrhosis) 01/2019 - 05/2010
4	Porcine Reproductive and Respiratory Syndrome (PRRS) 03/2016 - 09/2009
4	Arthritis (Polyarthritis) 02/2016 - 02/2013
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022 - 09/2013
3	Familial Mediterranean Fever (Periodic Disease) 01/2020 - 02/2013
3	Sepsis (Septicemia) 01/2019 - 07/2006
3	Atherosclerosis 08/2013 - 07/2006
2	RNA Virus Infections 01/2021 - 01/2019
2	Colitis 01/2020 - 09/2010
2	Septic Shock (Toxic Shock Syndrome) 01/2020 - 11/2019
2	Bacterial Infections (Bacterial Infection) 01/2019 - 01/2017
2	Myocardial Infarction 12/2017 - 07/2013
2	Splenomegaly 02/2016 - 07/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2015 - 03/2012
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 08/2015 - 10/2013
2	Fever (Fevers) 01/2014 - 02/2013
2	Alzheimer Disease (Alzheimer's Disease) 08/2013 - 08/2008
2	Candidiasis (Moniliasis) 12/2011 - 05/2009
1	Rheumatic Diseases (Rheumatism) 10/2022
1	Chilblain lupus 1 10/2022
1	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2022

Drug/Important Bio-Agent (IBA)

43	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 11/2006
39	InflammasomesIBA 01/2020 - 08/2008
27	CytokinesIBA 01/2019 - 05/2009
26	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
19	InterferonsIBA 01/2022 - 09/2005
19	Interferon Type IIBA 01/2021 - 09/2005
12	Antiviral Agents (Antivirals)IBA 01/2019 - 07/2009
10	Pattern Recognition ReceptorsIBA 03/2016 - 07/2006
8	Nucleic AcidsIBA 01/2021 - 04/2007
8	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2019 - 07/2013
8	Phosphotransferases (Kinase)IBA 01/2019 - 08/2011
8	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 01/2004
7	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2007
7	Interleukin-18 (Interleukin 18)IBA 05/2014 - 04/2010
6	AutoantibodiesIBA 10/2022 - 02/2015
6	LigandsIBA 01/2018 - 08/2013
6	NucleotidesIBA 11/2015 - 07/2012
6	Interleukin-1 (Interleukin 1)IBA 02/2013 - 04/2010
5	Caspase 8 (Caspase-8)IBA 11/2020 - 11/2013
5	InterleukinsIBA 12/2016 - 04/2010
4	LipopolysaccharidesIBA 01/2020 - 01/2004
4	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 12/2017 - 05/2013
4	deoxyribonuclease II (DNASE II)IBA 02/2017 - 03/2013
4	Leucine (L-Leucine)FDA Link 09/2015 - 07/2012
3	CaspasesIBA 01/2020 - 10/2005
3	Peptides (Polypeptides)IBA 01/2020 - 08/2008
3	Uric Acid (Urate)IBA 01/2020 - 08/2015
3	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 10/2011
3	PyrinIBA 01/2016 - 03/2009
3	Adenosine Triphosphate (ATP)IBA 11/2015 - 03/2012
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2014 - 10/2005
3	Transcription Factors (Transcription Factor)IBA 05/2014 - 12/2002
3	RNA Helicases (RNA Helicase)IBA 01/2014 - 10/2005
3	VaccinesIBA 01/2014 - 08/2008
3	CholesterolIBA 08/2013 - 02/2009
3	Chemokine CCL5IBA 08/2008 - 01/2004
3	ChemokinesIBA 08/2008 - 01/2004
3	NF-kappa B (NF-kB)IBA 09/2005 - 12/2002
2	AntigensIBA 10/2022 - 03/2016
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2013
2	bis(3',5')-cyclic diguanylic acidIBA 01/2021 - 03/2014
2	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2008
2	Pharmaceutical PreparationsIBA 11/2019 - 05/2013
2	Biological ProductsIBA 11/2019 - 01/2018
2	Long Noncoding RNAIBA 01/2019 - 06/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 01/2013
2	LipidsIBA 01/2018 - 02/2009
2	hemozoinIBA 01/2018 - 01/2014
2	Fas Ligand Protein (Fas Ligand)IBA 01/2018 - 09/2013
2	Toll-Like Receptor 4IBA 12/2016 - 08/2012
2	EndotoxinsIBA 06/2016 - 08/2012
2	DNA VaccinesIBA 01/2016 - 01/2015
2	DNA receptor (receptor, DNA)IBA 01/2016 - 04/2012
2	Silicon Dioxide (Silica)FDA LinkGeneric 11/2015 - 08/2008
2	Poly I-CIBA 08/2015 - 09/2005
2	pristane (pristan)IBA 02/2015 - 09/2013
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2014 - 10/2013
2	vadimezanIBA 05/2013 - 11/2012
2	Interleukin-17 (Interleukin 17)IBA 07/2011 - 11/2010
2	Interleukin-1alpha (Interleukin 1 alpha)IBA 07/2009 - 11/2006
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2004 - 05/2003
1	ChromatinIBA 01/2022
1	Hepatocyte Nuclear Factor 4IBA 01/2022
1	TransposasesIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022

Therapy/Procedure

8	Therapeutics 10/2022 - 04/2010
2	Immunotherapy 01/2021 - 11/2014
2	Oral Administration 01/2020 - 09/2010
2	Ligation 01/2018 - 07/2013